Fugitive medical and patient-derived aerosol particle distribution following heparin nebulization in patients with COVID-19 acute hypoxemic respiratory failure: a secondary analysis of the CHARTER study

• Michael Walsh,
• Marc Mac Giolla Eain,
• Ronan MacLoughlin,
• John Laffey,
• Bairbre McNicholas

Affiliations

Michael Walsh

Department of Anaesthesia and Intensive Care Medicine, University Hospital Galway

Marc Mac Giolla Eain

Research and Development, Science and Emerging Technology, Aerogen Ltd.

Ronan MacLoughlin

Research and Development, Science and Emerging Technology, Aerogen Ltd.

John Laffey

Department of Anaesthesia and Intensive Care Medicine, University Hospital Galway

Bairbre McNicholas

Department of Anaesthesia and Intensive Care Medicine, University Hospital Galway